Low serum cortisol in term newborns with refractory hypotension

Phuket Tantivit, Nirupama Subramanian, Meena Garg, Rangasamy Ramanathan, Robert A. DeLemos

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

OBJECTIVES: The aim of this study is to measure baseline serum cortisol levels and clinical response to glucocorticoid therapy in a group of term infants with refractory hypotension. STUDY DESIGN: Seven term newborns with refractory hypotension were included. Serum cortisol levels were drawn before initiation of glucocorticoid therapy and measured by either fluorescence polarization immunoassay or radioimmunoassay. Baseline blood pressures, heart rate, and inotropes doses were recorded at baseline, then 4,8,12,24,48,72, and 96 hours after glucocorticoid therapy. Urine output and volume expanders the infants received were recorded 24 hours before and after glucocorticoid therapy. Dexamethasone was used at a starting dose of 0.2 mg/kg per day divided every 12 hours. The statistical analysis was done using analysis of variance with repeated measures and paired t-test. RESULTS: Serum cortisol levels of the infants ranged from 2.0 to 15.4 μg/dl. After initiation of glucocorticoid therapy, there was significant improvement of blood pressure. Vasopressors were rapidly weaned and discontinued within 72 hours. In three of seven infants, no volume expanders were required after initiation of steroids, and none needed volume expanders after 2 days. Urine output increased significantly within 24 hours. All infants survived. CONCLUSIONS: Glucocorticoids improved pressure and stabilized clinical conditions of a group of term newborns with refractory hypotension. Serum cortisol levels of these infants were relatively low. We speculate that a subset of critically ill term infants has relative adrenal insufficiency and glucocorticoid therapy may be essential.

Original languageEnglish (US)
Pages (from-to)352-357
Number of pages6
JournalJournal of Perinatology
Volume19
Issue number5
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

Hypotension
Glucocorticoids
Hydrocortisone
Newborn Infant
Serum
Therapeutics
Urine
Fluorescence Polarization Immunoassay
Blood Pressure
Adrenal Insufficiency
Critical Illness
Dexamethasone
Radioimmunoassay
Analysis of Variance
Heart Rate
Steroids
Pressure

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Tantivit, P., Subramanian, N., Garg, M., Ramanathan, R., & DeLemos, R. A. (1999). Low serum cortisol in term newborns with refractory hypotension. Journal of Perinatology, 19(5), 352-357.

Low serum cortisol in term newborns with refractory hypotension. / Tantivit, Phuket; Subramanian, Nirupama; Garg, Meena; Ramanathan, Rangasamy; DeLemos, Robert A.

In: Journal of Perinatology, Vol. 19, No. 5, 07.1999, p. 352-357.

Research output: Contribution to journalArticle

Tantivit, P, Subramanian, N, Garg, M, Ramanathan, R & DeLemos, RA 1999, 'Low serum cortisol in term newborns with refractory hypotension', Journal of Perinatology, vol. 19, no. 5, pp. 352-357.
Tantivit P, Subramanian N, Garg M, Ramanathan R, DeLemos RA. Low serum cortisol in term newborns with refractory hypotension. Journal of Perinatology. 1999 Jul;19(5):352-357.
Tantivit, Phuket ; Subramanian, Nirupama ; Garg, Meena ; Ramanathan, Rangasamy ; DeLemos, Robert A. / Low serum cortisol in term newborns with refractory hypotension. In: Journal of Perinatology. 1999 ; Vol. 19, No. 5. pp. 352-357.
@article{d446a636b0974791a55b25b1c77ba53b,
title = "Low serum cortisol in term newborns with refractory hypotension",
abstract = "OBJECTIVES: The aim of this study is to measure baseline serum cortisol levels and clinical response to glucocorticoid therapy in a group of term infants with refractory hypotension. STUDY DESIGN: Seven term newborns with refractory hypotension were included. Serum cortisol levels were drawn before initiation of glucocorticoid therapy and measured by either fluorescence polarization immunoassay or radioimmunoassay. Baseline blood pressures, heart rate, and inotropes doses were recorded at baseline, then 4,8,12,24,48,72, and 96 hours after glucocorticoid therapy. Urine output and volume expanders the infants received were recorded 24 hours before and after glucocorticoid therapy. Dexamethasone was used at a starting dose of 0.2 mg/kg per day divided every 12 hours. The statistical analysis was done using analysis of variance with repeated measures and paired t-test. RESULTS: Serum cortisol levels of the infants ranged from 2.0 to 15.4 μg/dl. After initiation of glucocorticoid therapy, there was significant improvement of blood pressure. Vasopressors were rapidly weaned and discontinued within 72 hours. In three of seven infants, no volume expanders were required after initiation of steroids, and none needed volume expanders after 2 days. Urine output increased significantly within 24 hours. All infants survived. CONCLUSIONS: Glucocorticoids improved pressure and stabilized clinical conditions of a group of term newborns with refractory hypotension. Serum cortisol levels of these infants were relatively low. We speculate that a subset of critically ill term infants has relative adrenal insufficiency and glucocorticoid therapy may be essential.",
author = "Phuket Tantivit and Nirupama Subramanian and Meena Garg and Rangasamy Ramanathan and DeLemos, {Robert A.}",
year = "1999",
month = "7",
language = "English (US)",
volume = "19",
pages = "352--357",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Low serum cortisol in term newborns with refractory hypotension

AU - Tantivit, Phuket

AU - Subramanian, Nirupama

AU - Garg, Meena

AU - Ramanathan, Rangasamy

AU - DeLemos, Robert A.

PY - 1999/7

Y1 - 1999/7

N2 - OBJECTIVES: The aim of this study is to measure baseline serum cortisol levels and clinical response to glucocorticoid therapy in a group of term infants with refractory hypotension. STUDY DESIGN: Seven term newborns with refractory hypotension were included. Serum cortisol levels were drawn before initiation of glucocorticoid therapy and measured by either fluorescence polarization immunoassay or radioimmunoassay. Baseline blood pressures, heart rate, and inotropes doses were recorded at baseline, then 4,8,12,24,48,72, and 96 hours after glucocorticoid therapy. Urine output and volume expanders the infants received were recorded 24 hours before and after glucocorticoid therapy. Dexamethasone was used at a starting dose of 0.2 mg/kg per day divided every 12 hours. The statistical analysis was done using analysis of variance with repeated measures and paired t-test. RESULTS: Serum cortisol levels of the infants ranged from 2.0 to 15.4 μg/dl. After initiation of glucocorticoid therapy, there was significant improvement of blood pressure. Vasopressors were rapidly weaned and discontinued within 72 hours. In three of seven infants, no volume expanders were required after initiation of steroids, and none needed volume expanders after 2 days. Urine output increased significantly within 24 hours. All infants survived. CONCLUSIONS: Glucocorticoids improved pressure and stabilized clinical conditions of a group of term newborns with refractory hypotension. Serum cortisol levels of these infants were relatively low. We speculate that a subset of critically ill term infants has relative adrenal insufficiency and glucocorticoid therapy may be essential.

AB - OBJECTIVES: The aim of this study is to measure baseline serum cortisol levels and clinical response to glucocorticoid therapy in a group of term infants with refractory hypotension. STUDY DESIGN: Seven term newborns with refractory hypotension were included. Serum cortisol levels were drawn before initiation of glucocorticoid therapy and measured by either fluorescence polarization immunoassay or radioimmunoassay. Baseline blood pressures, heart rate, and inotropes doses were recorded at baseline, then 4,8,12,24,48,72, and 96 hours after glucocorticoid therapy. Urine output and volume expanders the infants received were recorded 24 hours before and after glucocorticoid therapy. Dexamethasone was used at a starting dose of 0.2 mg/kg per day divided every 12 hours. The statistical analysis was done using analysis of variance with repeated measures and paired t-test. RESULTS: Serum cortisol levels of the infants ranged from 2.0 to 15.4 μg/dl. After initiation of glucocorticoid therapy, there was significant improvement of blood pressure. Vasopressors were rapidly weaned and discontinued within 72 hours. In three of seven infants, no volume expanders were required after initiation of steroids, and none needed volume expanders after 2 days. Urine output increased significantly within 24 hours. All infants survived. CONCLUSIONS: Glucocorticoids improved pressure and stabilized clinical conditions of a group of term newborns with refractory hypotension. Serum cortisol levels of these infants were relatively low. We speculate that a subset of critically ill term infants has relative adrenal insufficiency and glucocorticoid therapy may be essential.

UR - http://www.scopus.com/inward/record.url?scp=0033154884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033154884&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 352

EP - 357

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 5

ER -